This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Intentional self-harm by hanging, strangulation and suffocation
VWXY20_INTENTI_SELF_H_HANGI_STRANGU_SUFFO
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
313 |
4. Check minimum number of eventsNone |
313 |
5. Include endpointsNone |
313 |
6. Filter based on genotype QC (FinnGen only) |
271 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X[6-7]|X8[0-4]
Similar endpoints
↥List of similar endpoints to
Intentional self-harm by hanging, strangulation and suffocation
based on the number of shared cases.
Similar with more cases:
- Suicide or other Intentional self-harm
- Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders
- Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls
- Any mental disorder
- External causes of morbidity and mortality
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 271 | 49 | 222 |
| Unadjusted period prevalence (%) | 0.09 | 0.02 | 0.10 |
| Median age at first event (years) | 51.81 | 39.11 | 54.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 277
- Matched controls
- 2770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X70
ICD-10 Finland
Intentional self-harm by hanging, strangulation and suffocation
+∞
307.7
277
*
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
45.5
85.6
52
14
F32.9
ICD-10 Finland
Depressive episode, unspecified
10.9
84.5
123
189
T36
ICD-10 Finland
Poisoning by systemic antibiotics
15.3
71.6
70
60
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
17.6
65.9
58
41
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
8.7
44.9
65
94
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
16.7
38.9
34
23
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.8
34.1
61
110
A98
ICPC
Health maint/preventive medicine
0.2
32.4
156
2360
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
10.0
27.4
33
37
N05AH04
ATC
quetiapine; oral
4.0
25.1
99
340
N05AH03
ATC
olanzapine; systemic
5.3
22.3
50
110
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.8
22.1
57
141
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
6.0
18.6
35
65
N06AX11
ATC
mirtazapine; oral
3.0
17.6
124
589
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.7
17.5
35
69
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.2
17.0
51
141
N06AX16
ATC
venlafaxine; oral
3.7
16.6
62
200
N06AB04
ATC
citalopram; systemic
3.3
16.3
76
283
N05BA04
ATC
oxazepam; oral
3.1
16.2
94
398
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.2
15.2
45
123
N07BB01
ATC
disulfiram; oral
4.9
15.0
35
79
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
26.8
14.9
20
8
N06AB03
ATC
fluoxetine; oral
3.9
14.3
47
138
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
14.6
14.0
23
17
N02BE01
ATC
paracetamol; systemic, rectal
0.4
11.8
148
2040
N03AX09
ATC
lamotrigine; oral
4.9
11.7
27
60
N05AA02
ATC
levomepromazine; systemic
5.0
11.7
26
56
N05AB03
ATC
perphenazine; systemic, rectal
5.9
11.4
21
38
F32
ICD-10 Finland
Depressive episode
5.0
10.7
24
52
AA400
NOMESCO Finland
Electroconvulsive therapy
19.7
10.4
15
8
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.6
10.3
25
58
N06AB10
ATC
escitalopram; oral
2.6
10.2
75
349
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
17.5
10.0
15
9
Z91.5
ICD-10 Finland
Personal history of self-harm
57.0
9.7
11
*
N05AF03
ATC
chlorprothixene; systemic
8.5
9.5
20
25
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
18.3
9.5
14
8
OAA67, ,
SPAT
0.1
9.2
5
346
N05BA01
ATC
diazepam; systemic, rectal
2.9
9.2
47
181
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.2
9.1
25
64
OAB43, ,
SPAT
0.3
8.9
27
735
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
7.0
8.8
21
32
N06AB06
ATC
sertraline; oral
2.9
8.7
44
168
F19.0
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, acute intoxication
+∞
8.4
8
*
T71
ICD-10 Finland
Asphyxiation
+∞
8.4
8
*
N05AX08
ATC
risperidone; systemic
3.0
8.4
40
148
N05AX12
ATC
aripiprazole; systemic
4.0
8.3
24
64
N05CF01
ATC
zopiclone; oral
2.2
8.3
94
525
P15
ICPC
Chronic alcohol abuse
4.1
8.2
23
60
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
19.0
7.7
11
6
SPAT1240
SPAT
Therapeutic discussion
2.8
7.3
40
159
X84
ICD-10 Finland
Intentional self-harm by unspecified means
30.9
7.2
9
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.5
7.2
25
76
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.5
7.1
12
10
ZY000
NOMESCO Finland
Hospital inpatient
12.5
7.1
12
10
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.2
7.1
9
364
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
10.4
7.1
13
13
WW200, ,
SPAT
0.2
6.9
13
474
N06AX12
ATC
bupropion; oral
3.0
6.8
32
117
S10.9
ICD-10 Finland
Superficial injury of neck, part unspecified
41.1
6.8
8
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
23.2
6.7
9
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
23.2
6.7
9
*
N06AX21
ATC
duloxetine; oral
2.8
6.7
35
136
P19
ICPC
Drug abuse
10.4
6.6
12
12
P03
ICPC
Feeling depressed
2.7
6.5
38
156
N03AG01
ATC
valproic acid; systemic, rectal
3.4
6.5
24
76
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.8
6.4
17
31
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.5
6.4
13
16
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.2
6.4
16
27
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
7.0
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
171
2397
0.25
26.11
22.8
22.2
4.64
4.65
e12/l
0.15
166
2361
171
2394
0.25
25.77
22.9
22.3
254.52
242.07
e9/l
1.47
166
2362
144
2181
0.29
22.42
4.2
5.2
2.75
2.74
mmol/l
0.08
131
2054
141
2151
0.30
21.78
4.0
4.6
1.34
1.34
mmol/l
0.00
132
2023
142
2156
0.30
21.60
4.0
4.7
4.61
4.56
mmol/l
0.23
132
2038
167
2302
0.31
19.26
11.8
11.1
29.92
30.66
u/l
0.18
160
2259
74
1535
0.29
18.88
3.1
3.3
—
—
—
0
0
135
2051
0.33
18.05
3.5
4.0
1.52
1.34
mmol/l
0.70
125
1922
136
2044
0.34
17.15
14.8
14.0
95.49
86.84
ml/min/173m2
5.83
124
1878
130
1996
0.34
17.15
5.1
5.8
38.85
38.92
mmol/mol
0.03
119
1904
153
2152
0.35
15.72
17.2
15.1
16.46
26.45
mg/l
6.38
125
1767
141
2015
0.39
13.36
4.4
4.6
5.86
5.93
mmol/l
0.27
129
1874
57
1139
0.37
10.42
3.4
4.7
1.70
2.24
ug/l
0.80
52
1031
39
914
0.33
9.83
3.2
4.1
21.37
21.83
%
0.06
17
388
127
1811
0.45
9.74
18.4
18.3
13.31
13.48
%
0.95
127
1797
16
15
11.24
8.91
11.2
1.3
157.14
110.20
umol/l
—
7
5
28
703
0.33
7.67
1.9
2.8
0.55
0.79
ug/l
2.33
20
392
64
1095
0.46
6.95
4.1
3.3
0.00
1.54
estimate
0.50
13
195
107
1523
0.52
6.56
4.9
4.0
11.06
10.51
mm/h
0.18
100
1428
65
1084
0.48
6.39
4.2
3.3
0.00
0.00
estimate
-0.00
15
212
54
957
0.46
6.26
3.1
2.9
—
—
estimate
—
0
0
65
1075
0.48
6.17
4.2
3.3
0.07
0.00
estimate
0.47
14
210
29
643
0.39
5.80
4.2
4.2
17.83
13.07
mg/mmol
0.12
15
444
68
382
2.03
5.63
2.5
2.1
1.65
1.51
%
0.70
63
344
148
1874
0.55
5.61
4.6
4.4
1.70
1.87
mu/l
1.41
139
1737
133
1680
0.60
4.24
5.3
3.3
43.30
49.21
u/l
0.61
122
1607
87
1222
0.58
4.22
8.1
10.3
4.15
4.22
e9/l
0.13
75
1068
126
1601
0.61
3.98
8.6
8.4
76.73
79.92
u/l
0.36
120
1535
12
29
4.28
3.75
1.3
2.1
—
—
—
0
0
53
829
0.55
3.68
4.1
3.2
0.00
0.03
estimate
0.78
12
183
36
630
0.51
3.61
3.6
2.8
0.00
0.16
estimate
0.55
12
168
33
571
0.52
3.15
2.8
2.8
337.71
363.16
umol/l
1.02
28
512
28
506
0.50
3.05
3.4
2.5
—
—
—
0
0
35
583
0.54
2.92
3.2
3.2
723.76
1398.48
ng/l
1.29
29
477
60
865
0.61
2.91
1.8
2.5
70.68
71.56
nmol/l
0.07
54
783
29
508
0.52
2.85
1.4
1.3
0.45
1.40
u/ml
—
6
135
24
444
0.50
2.79
1.4
1.6
—
—
—
0
0
35
557
0.57
2.45
3.5
3.0
0.15
0.31
e6/l
1.01
25
417
62
859
0.64
2.45
1.7
2.0
95.31
91.98
pmol/l
0.21
35
472
128
1517
0.71
2.11
3.8
3.5
14.60
14.69
pmol/l
0.16
116
1385
21
367
0.54
2.04
2.0
1.9
—
—
—
0
0
13
261
0.47
1.92
1.4
1.8
—
—
—
0
0
14
270
0.49
1.85
1.4
1.7
—
—
—
0
0
5
13
3.90
1.72
1.0
1.2
—
—
—
0
0
90
1105
0.73
1.72
7.9
7.1
8.74
12.40
umol/l
5.44
82
1065
18
307
0.56
1.62
1.5
2.6
23.53
24.11
%
0.07
18
292
21
342
0.58
1.60
2.0
2.8
1.38
0.88
e6/l
—
6
182
19
312
0.58
1.50
1.4
1.3
66.24
6.09
u/ml
—
5
119
22
347
0.60
1.48
1.4
1.3
34.33
30.69
iu/ml
—
6
96
6
22
2.76
1.44
1.2
1.1
—
—
—
0
0
24
361
0.63
1.33
2.1
2.1
29.71
29.23
s
0.20
24
351
30
429
0.66
1.32
4.6
3.3
2900.90
679.22
ng/l
0.45
21
319
6
135
0.43
1.31
7.3
3.5
98.50
144.96
ng/l
—
6
112
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
6
24
2.53
1.31
1.2
1.1
—
—
—
0
0
42
307
1.43
1.27
1.7
1.8
1102.45
1138.63
nmol/l
0.12
36
241
39
520
0.71
1.18
2.1
2.1
3.63
2.81
mg/l
1.16
31
460
0
34
0.00
1.16
0.0
1.4
—
—
—
0
0
0
36
0.00
1.14
0.0
1.6
—
—
—
0
0
68
828
0.76
1.14
4.1
3.7
61.79
43.35
ng/l
0.17
47
563
83
975
0.79
1.03
6.9
8.2
1.20
1.20
mmol/l
0.06
73
861
23
327
0.68
1.00
2.1
2.9
1.13
1.02
e6/l
—
8
166
45
570
0.75
0.99
4.7
3.3
0.00
0.02
estimate
0.74
14
194
0
30
0.00
0.98
0.0
1.1
—
8.45
—
0
23
6
117
0.50
0.96
1.8
1.8
—
—
—
0
0
7
129
0.53
0.90
3.1
1.8
148.43
237.87
pmol/l
—
7
121
6
30
2.02
0.87
1.0
1.4
—
—
—
0
0
18
122
1.51
0.82
1.4
1.4
—
—
—
0
0
10
58
1.75
0.80
2.9
2.5
—
346.37
u/l
—
0
19
7
121
0.57
0.80
1.7
1.3
—
—
—
0
0
7
124
0.55
0.80
1.7
3.8
145.29
132.08
g/l
—
7
119
10
162
0.60
0.79
1.1
1.4
—
—
—
0
0
0
24
0.00
0.79
0.0
1.4
—
49.37
—
0
24
0
28
0.00
0.76
0.0
2.0
—
23.17
—
0
12
5
92
0.54
0.68
1.4
2.2
56.80
40.44
u/l
—
5
83
5
28
1.80
0.66
1.8
1.8
—
—
—
0
0
5
28
1.80
0.66
3.6
2.3
10.80
10.96
mmol/l
—
5
28
82
920
0.85
0.60
3.9
5.1
35.73
36.41
g/l
0.50
75
875
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
17
123
1.41
0.59
9.1
13.0
17.51
16.42
%
0.87
17
116
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
6
38
1.59
0.54
1.0
1.2
—
—
—
0
0
11
157
0.69
0.53
1.3
1.6
—
—
—
0
0
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
17
129
1.34
0.47
1.3
1.2
—
14.97
—
0
7
7
49
1.44
0.46
1.6
1.2
—
—
—
0
0
13
173
0.74
0.43
2.2
2.5
1.05
0.15
e6/l
0.42
13
168
25
304
0.80
0.43
10.2
7.4
103.68
104.55
mmol/l
0.32
25
304
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
7
103
0.67
0.40
2.3
4.5
57.03
53.06
%
—
7
98
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
44
501
0.86
0.39
4.0
3.3
1.02
1.02
kg/l
0.19
28
335
7
52
1.35
0.31
1.1
1.3
—
—
—
0
0
7
97
0.71
0.31
1.4
1.4
—
—
—
0
0
5
73
0.68
0.26
1.0
1.1
—
16.99
—
0
7
11
137
0.79
0.25
17.5
8.3
23.55
24.48
mmol/l
0.51
11
137
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
2.5
—
126.64
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
1170.92
—
0
12
0
12
0.00
0.21
0.0
2.8
—
13.67
—
0
12
0
12
0.00
0.21
0.0
2.2
—
204.67
—
0
12
0
12
0.00
0.21
0.0
3.2
—
1.17
—
0
12
0
13
0.00
0.21
0.0
1.0
—
1421.46
—
0
13
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
4.3
—
70.36
—
0
14
15
175
0.85
0.19
1.9
2.4
6.42
9.79
ug/l
—
9
158
24
213
1.14
0.19
10.3
11.2
128.29
125.16
g/l
0.30
24
206
10
121
0.82
0.18
2.4
1.8
—
—
—
0
0
22
197
1.13
0.16
6.4
3.5
—
—
—
0
0
18
203
0.88
0.16
1.4
4.0
2.30
1.40
mmol/l
0.35
13
167
9
79
1.14
0.15
9.6
3.7
23.93
24.61
mmol/l
—
9
72
18
161
1.13
0.13
3.5
2.5
—
—
—
0
0
22
200
1.11
0.13
6.7
8.3
—
—
—
0
0
15
133
1.14
0.12
5.0
10.5
25.47
24.12
mmol/l
1.54
15
125
21
230
0.91
0.12
4.0
4.5
28.56
30.16
%
0.37
16
153
66
634
1.05
0.11
2.5
3.3
2.33
2.34
mmol/l
0.37
61
583
36
339
1.07
0.10
2.7
2.2
—
—
—
0
0
16
144
1.12
0.10
2.3
2.4
—
—
—
0
0
11
97
1.14
0.09
4.3
9.4
2.90
1.58
%
1.04
11
88
39
371
1.06
0.09
2.8
2.3
—
—
—
0
0
6
55
1.09
0.09
1.3
1.8
—
—
—
0
0
12
107
1.13
0.08
1.7
1.3
4.85
5.73
u/l
0.27
12
88
6
73
0.82
0.07
2.3
2.5
—
—
—
0
0
16
147
1.09
0.07
6.1
2.9
5.38
5.05
kpa
0.54
16
141
21
196
1.08
0.07
7.4
8.1
6.64
9.53
mmol/l
1.34
21
187
16
148
1.09
0.06
1.6
1.5
—
—
—
0
0
13
132
0.98
0.00
1.4
1.2
98.42
108.32
u/ml
—
5
50
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
161.57
—
0
7
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.27
—
0
9
0
8
0.00
-0.00
0.0
1.3
—
8.59
—
0
8
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
29
290
1.00
-0.00
3.2
7.1
1.04
1.01
mmol/l
0.19
29
272
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
69.12
—
0
5
5
52
0.96
-0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
36.40
—
0
5
0
6
0.00
-0.00
0.0
3.0
—
189.75
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
25
250
1.00
-0.00
10.8
10.0
11.45
12.23
kpa
0.43
25
239
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
35.22
—
0
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
-0.00
0.0
1.1
—
96.88
—
0
8
25
250
1.00
-0.00
10.8
10.0
5.38
5.08
kpa
1.55
25
237
8
79
1.01
-0.00
2.6
2.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
7
74
0.94
-0.00
2.6
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_INTENTI_SELF_H_HANGI_STRANGU_SUFFO – Intentional self-harm by hanging, strangulation and suffocation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).